Vladimir Keil, co-founder and CEO of Leo, argues that the hardest part of deploying an AI agent in the enterprise is not building it but earning ...
Opinion
Dario Amodei's $2 Trillion Bet: Inside the White House AI Theater and Anthropic's $500B Debt Bomb
A single week in late September 2026 crystallized the violent contradictions of the AI boom. President Trump gathered nearly twenty tech leaders ...
Carlos Alcaraz beats Matteo Arnaldi and advances to the quarterfinals of the ATP Tokyo. Today, Saturday, October 3, the Spanish tennis player defeated the Italian in two sets with a score of 7-6 (8-6) ...
Boehringer Ingelheim reported positive Phase III SYNCHRONIZE-2 results for investigational survodutide (BI 456906) in adults living with obesity or overweight and type 2 diabetes.
Fresenius brings mAbxience fully into its Biopharma business with acquisition of remaining 45% stake
Fresenius SE & Co. KGaA has acquired the remaining 45% of mAbxience Holding S.L. from Insud Pharma S.L. and Invim Corporativo, S.L. for up to €750 million, including a €50 mil ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results